Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression
about
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Insulin resistance and steatos ...... on liver fibrosis progression
@ast
Insulin resistance and steatos ...... on liver fibrosis progression
@en
Insulin resistance and steatos ...... on liver fibrosis progression
@nl
type
label
Insulin resistance and steatos ...... on liver fibrosis progression
@ast
Insulin resistance and steatos ...... on liver fibrosis progression
@en
Insulin resistance and steatos ...... on liver fibrosis progression
@nl
prefLabel
Insulin resistance and steatos ...... on liver fibrosis progression
@ast
Insulin resistance and steatos ...... on liver fibrosis progression
@en
Insulin resistance and steatos ...... on liver fibrosis progression
@nl
P2093
P2860
P50
P356
P1476
Insulin resistance and steatos ...... on liver fibrosis progression
@en
P2093
Adriana Boemio
Aldo Marrone
Carmine Minichini
Emanuele Miraglia Del Giudice
Giovanna Salzillo
Grazia Cirillo
Luciano Restivo
Luigi Elio Adinolfi
Maria Chiara Fascione
Mario Starace
P2860
P304
P356
10.4254/WJH.V6.I9.677
P577
2014-09-01T00:00:00Z